Skip to main content
. 2013 Feb;98(2):e18–e19. doi: 10.3324/haematol.2012.071050

Figure 1.

Figure 1.

(A) Kaplan-Meier estimates of the overall survival after azacitidine failure in low and int-1 IPSS MDS patients. (B) Survival estimates according to WPSS. Curves represent survival estimates of patients. Each tick mark represents a censored patient. Low and Int: includes patients with very low, low and intermediate WPSS scores.